Amneal Pharmaceuticals shares owned by Connor, Clark & Lunn Investment Management
Quarter-by-quarter ownership of Amneal Pharmaceuticals (AMRX) shares owned by Connor, Clark & Lunn Investment Management
from 13F filings
Historical chart of Connor, Clark & Lunn Investment Management investment in Amneal Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Amneal Pharmaceuticals held by Connor, Clark & Lunn Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Amneal Pharmaceuticals by Connor, Clark & Lunn Investment Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $3.2M | 533k | 6.06 |
| 2023-12-31 | $2.9M | 477k | 6.07 |
| 2023-09-30 | $2.1M | 492k | 4.22 |
| 2023-06-30 | $1.2M | 385k | 3.10 |
| 2023-03-31 | $459k | 331k | 1.39 |
| 2022-12-31 | $466k | 234k | 1.99 |
| 2022-09-30 | $310k | 154k | 2.02 |
| 2020-09-30 | $70k | 18k | 3.89 |
| 2020-06-30 | $1.4M | 299k | 4.76 |
| 2020-03-31 | $634k | 182k | 3.48 |
More positions owned by Connor, Clark & Lunn Investment Management
View all positions for Connor, Clark & Lunn Investment Management